← Scroll for more →
Cartesian Therapeutics, Inc. (RNAC)
Pharmaceutical Preparations
Latest Price
$6.46
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
0.04
P/B Ratio
183.52
Institutional Ownership
29.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Squarepoint Ops LLC | 2.25M | $23.0M | 7.51% | +16.1K | 2026-06-30 |
| BlackRock, Inc. | 819.2K | $8.0M | 2.73% | +220.1K | 2026-06-30 |
| 683 Capital Management, LLC | 650.0K | $6.0M | 2.16% | +320.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 555.8K | $5.0M | 1.85% | +148.2K | 2026-06-30 |
| FMR LLC | 368.4K | $3.0M | 1.23% | -431.3K | 2026-06-30 |
| Geode Capital Management, LLC | 356.5K | $3.0M | 1.19% | +92.8K | 2026-06-30 |
| AQR Capital Management LLC | 356.5K | $3.0M | 1.19% | +272.4K | 2026-06-30 |
| Millennium Management LLC | 309.9K | $3.0M | 1.03% | +25.6K | 2026-06-30 |
| Two Sigma Investments, LP | 296.3K | $3.0M | 0.99% | -- | 2026-06-30 |
| State Street Corp | 249.2K | $2.0M | 0.83% | +48.9K | 2026-06-30 |